Global Sexual Dysfunction Drugs Market 2017-2021

Overview of the global sexual dysfunction drugs market

It has been observed that the rising incidence of diseases including diabetes mellitus, cardiovascular diseases (CVD), psychiatric or psychological disorders such as depression and Parkinson's disease, and chronic diseases such as prostate cancer, accelerate the development of sexual dysfunctions. Research analysis on the global sexual dysfunction drugs market identifies that the increase in risk factors causing sexual dysfunctions will be one of the major factors that will have a positive impact on the growth of the market.

The treatment for prostate cancer requires the removal of the prostate gland. This, in turn, can result in impaired sexual function in men. Similarly, patients with diabetes, hypertension, hypercholesterolemia, and other conditions such as obesity are prone to erectile dysfunction (ED). The chances that these patients will seek medical treatment for sexual dysfunctions are high. This, in turn, will drive the demand for sexual dysfunction drugs. Technavio’s market research analysts predict that this global market will post a revenue of almost USD 6 billion by 2021.

Get A Free Sample

Sexual dysfunction drugs market trends

Advancements in biomedical science are identified as one of the key trends that will gain traction in the global sexual dysfunction drugs market during the projected period. Advancements resulted in the emergence of nanotechnologies, which in turn, revolutionized the development of medicines such as erectile dysfunction drugs. Furthermore, the advancement in biomedical science has also enabled researchers to discover new targets for therapy and produce disease-modifying drugs (DMD) based on the understanding of the pathogenesis of a disease at its genetic and molecular level.

Sexual dysfunction drugs market worth: Competitive landscape and key vendors

The sexual dysfunction drugs market is characterized by the presence of various large and small players. These vendors are taking constant efforts to consolidate the market through increased strategic alliances and acquisitions. They are increasingly competing against each other based on factors such as geographical presence, stable supply chain logistics, patent expiry, and ongoing research trials.

Key vendors in the sexual dysfunction drugs market

• AbbVie
• Bayer
• Eli Lilly
• Pfizer

Sexual dysfunction drugs market segmentation by therapy

• Oral therapy
• Intracavernosal therapy
• Hormonal therapy
• Transurethral therapy

The sexual dysfunction oral drugs segment accounted for the majority market share during 2016 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

Sexual dysfunction drugs market segmentation by geography

• Americas
• APAC
• EMEA

The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population. Vendors in the region are increasingly focusing on launching low-cost substitutes of branded drugs for the treatment of sexual dysfunctions.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global sexual dysfunction drugs market?
• What are the key market trends impacting the growth of the global sexual dysfunction drugs market?
• What are the challenges to market growth?
• Who are the key vendors in the global sexual dysfunction drugs market?
• What are the market opportunities and threats faced by the vendors in the global sexual dysfunction drugs market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global sexual dysfunction drugs market?

Technavio also offers customization on reports based on specific client requirement.